Latest News for Genus Stock (OTC:GENSF)

Genus PLC is a biotechnology company that develops animal genetics for agricultural purposes. The company breeds and distributes the genes of pigs and bulls, scientifically selecting livestock whose offspring are designed to increase the profitability of its customers. In the porcine market, Genus sells boars and sows that produce offspring with desirable characteristics, such as feed-efficient growth or leaner meat. In the dairy and beef markets, the company's primary product is bull semen, which is delivered through artificial insemination to improve its customers' herds and their efficiency. Genus also offers embryos through its subsidiary IVB.

Genus PLC

Bronte Capital Amalthea Fund June 2023 Letter

Genus plc 2023 Q4 - Results - Earnings Call Presentation

Genus plc (GENSF) Q4 2023 Earnings Call Transcript

Genus: Playing Demographic Growth At The Breeding Edge

Bronte Capital Amalthea Fund September 2023 Letter

Genus GAAP EPS of 33.30p, revenue of £333.6M

Genus plc (GENSF) Q2 2024 Earnings Call Transcript

AAPL

BRK.A

BRK.B

CTLT

DSMFF

FFIE

FFIEW

GENSF

GENSY

GOOG

GOOGL

NKLA

NVDA

REGN

SRPT

WRCDF

Genus